Skip to main content

Table 1 Genomic coordinates of ERE-like sequences that have been experimentally validated or rejected as ER-binding

From: Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites

Name

Genomic location

Pattern

Validation

Reference

PDZK1

chr1:143,215,756-143,215,768

GGTCAcccAGTCC

Binding

This study

ADORA1

chr1:199,790,269-199,790,281

GGTTAgggTGACC

Binding

[10] and this study

ADORA1

chr1:199,790,414-199,790,426

GGTGTcttTGACC

Binding

This study

AGT

chr1:227,156,613-227,156,625

GGGCAtcgTGACC

Binding

[4]

GREB1

chr2:11,603,634-11,603,646

GGTCAaaaTGACC

Binding

[10]

GREB1

chr2:11,615,324-11,615,336

GGTCAtcaTGACC

Binding

[10]

GREB1

chr2:11,621,861-11,621,873

AGTCAgtgTCACC

Binding

This study

GREB1

chr2:11,623,258-11,623,270

GGTCAttcTGACC

Binding

[8,10]

CYP1B1

chr2:38,214,993-38,215,005

GGTCGcgcTGCCC

Binding

This study

CYP1B1

chr2:38,215,049-38,215,061

GGTCAaagCGGCC

Binding

This study

LTF

chr3:46,481,739-46,481,751

GGTCAaggCGATC

Binding

[10]

AREG

chr4:75,676,340-75,676,352

GGACAaggTGTCC

Binding

This study

ELOVL2

chr6:11,154,748-11,154,760

GGTCAtctTGATG

Binding

This study

VEGF

chr6:43,844,381-43,844,393

AATCAgacTGACT

Binding

[4]

LY6E

chr8:144,170,802-144,170,814

GGACAagaTGACC

Binding

[10]

PTGES

chr9:129,597,654-129,597,666

GGACAgccTGGCC

Binding

This study

CASP7

chr10:115,428,398-115,428,410

GGTCAgggTGAAC

Binding

[10]

CASP7

chr10:115,428,492-115,428,504

GGTCGgggTGAAC

Binding

[10]

CASP7

chr10:115,428,572-115,428,584

GGTCAgggTGAAC

Binding

[10]

CASP7

chr10:115,428,612-115,428,624

GGTCAgggTGAAC

Binding

[10]

CASP7

chr10:115,428,652-115,428,664

GGTCAgggTGAAC

Binding

[10]

CASP7

chr10:115,428,689-115,428,701

GGTCAgggTGAAC

Binding

[10]

CASP7

chr10:115,428,743-115,428,755

GGTCAgggTGAAC

Binding

[10]

CTSD

chr11:1,741,924-1,741,936

GGCCGggcTGACC

Binding

[4]

PGR

chr11:100,504,595-100,504,607

GGTCAccaGCTCT

Binding

[4]

PGR

chr11:100,505,180-100,505,192

GCAGGagcTGACC

Binding

[4]

SCNN1A

chr12:6,355,536-6,355,548

GGTCAgccTCACC

Binding

[10]

GAPDH

chr12:6,513,208-6,513,220

GGACAtcgTGACC

Binding

[10]

ESR2

chr14:63,879,248-63,879,260

GGTCAggcTGGTC

Binding

[4]

FLJ30973

chr15:55,670,850-55,670,862

GGGCAgtgTGGCC

Binding

This study

FLJ30973

chr15:55,671,545-55,671,557

GGTCAcccTGCTC

Binding

This study

ABCA3

chr16:2,319,793-2,319,805

GGTCAcggTGTTC

Binding

[8]

IGFBP4

chr17:35,849,113-35,849,125

GGTCAttgTGACA

Binding

[10]

TRIM25

chr17:52,323,321-52,323,333

GGTCAtggTGACC

Binding

[4], [10]

BCL2

chr18:59,136,673-59,136,685

GGTCGccaGGACC

Binding

[4]

MGC26694

chr19:19,035,118-19,035,130

GTTCAgagTGACC

Binding

This study

GRAMD1A

chr19:40,182,519-40,182,531

GGCCTggcTGACC

Binding

This study

ACTN4

chr19:43,897,093-43,897,105

GGTCActgTGACT

Binding

This study

GPR77

chr19:52,532,131-52,532,143

GGTCActcTGACA

Binding

This study

C3

chr19:6,671,884-6,671,902

GGTGGcccTGACC

Binding

[4]

NRIP1

chr21:15,359,833-15,359,845

GGTCAaagTGACC

Binding

[8]

TFF1

chr21:42,659,626-42,659,638

GGTCCtggTGTCC

Binding

This study

TFF1

chr21:42,659,906-42,659,918

AGCCAagaTGACC

Binding

This study

TFF1

chr21:42,660,106-42,660,118

GGTCAcggTGGCC

Binding

[4]

CRKL

chr22:19,595,695-19,595,707

AGTCAatcTAACC

Binding

This study

TSHB

chr1:115,283,928-115,283,940

GGTCAgctTGACA

Nonbinding

[10]

TXNIP

chr1:142,927,222-142,927,234

GGTCAgtgGGATC

Nonbinding

This study

LOR

chr1:150,045,850-150,045,862

GGTCCaaaGGACC

Nonbinding

This study

GREB1

chr2:11,622,443-11,622,455

TGCCAccaTGACC

Nonbinding

This study

GREB1

chr2:11,625,143-11,625,155

TGTCAatcTGTCC

Nonbinding

This study

EN1

chr2:119,322,563-119,322,575

GGTTAcccTGAAC

Nonbinding

This study

UGCGL1

chr2:128,563,200-128,563,212

TGTCAaaaTGTCC

Nonbinding

This study

UGCGL1

chr2:128,565,292-128,565,304

TGTCAcatTGAGC

Nonbinding

This study

PLGLB1

chr2:87,884,778-87,884,790

GGTCAgtgTGCCA

Nonbinding

This study

SIAH2

chr3:151,966,545-151,966,557

GCTCAtagTGCCC

Nonbinding

This study

ATP13A3

chr3:195,656,453-195,656,465

GGTCAttaATACC

Nonbinding

This study

CISH

chr3:50,626,609-50,626,621

GGCCAgagGGACC

Nonbinding

This study

LMCD1

chr3:8,517,591-8,517,603

GGCCTgcaTGACC

Nonbinding

This study

FLJ22269

chr4:673,249-673,261

GGGCAgagTGACT

Nonbinding

This study

CCNG2

chr4:78,433,176-78,433,188

GGACAactTGATC

Nonbinding

This study

STC2

chr5:172,689,912-172,689,924

GGGCAatgTGAAC

Nonbinding

This study

IL6ST

chr5:55,327,909-55,327,921

GGTGAgcaTGATC

Nonbinding

This study

PLK2

chr5:57,792,972-57,792,984

GGTTAcagCGACC

Nonbinding

This study

OLIG3

chr6:137,857,308-137,857,320

CGTCAtccTAACC

Nonbinding

This study

FKBPL

chr6:32,206,228-32,206,240

GGCCAgccCGACC

Nonbinding

This study

FKBPL

chr6:32,206,311-32,206,323

CGCCAccaTGACC

Nonbinding

This study

SERPINE1

chr7:100,361,980-100,361,992

GACCAgccTGACC

Nonbinding

This study

SERPINE1

chr7:100,362,938-100,362,950

GGACAagcTGCCC

Nonbinding

This study

SERPINE1

chr7:100,363,852-100,363,864

TGTCAagaAGACC

Nonbinding

This study

TSPAN13

chr7:16,566,080-16,566,092

GATAAgtcTGACC

Nonbinding

This study

BLVRA

chr7:43,570,289-43,570,301

GGTCActcTGGCT

Nonbinding

This study

BLVRA

chr7:43,570,774-43,570,786

AGTCAaccTTACC

Nonbinding

This study

B4GALT1

chr9:33,157,593-33,157,605

GCTCAacgCGACC

Nonbinding

This study

B4GALT1

chr9:33,158,622-33,158,634

GATCAgaaGGACC

Nonbinding

This study

DNAJC1

chr10:22,333,030-22,333,042

GTTCAactTGTCC

Nonbinding

This study

GAD2

chr10:26,545,037-26,545,049

GGTCGcagTGACC

Nonbinding

[10]

CXCL12

chr10:44,202,437-44,202,449

GGTCCagcTGCCC

Nonbinding

This study

CXCL12

chr10:44,203,283-44,203,295

TGTCAaaaTGGCC

Nonbinding

This study

PGR

chr11:100,509,203-100,509,215

AGTCAtgtTGACA

Nonbinding

This study

DGKZ

chr11:46,321,832-46,321,844

GGCCAtgcTGGCC

Nonbinding

This study

CTSW

chr11:65,403,499-65,403,511

GACCAgccTGACC

Nonbinding

This study

C14orf131

chr14:101,872,078-101,872,090

GGCCAacaTGACA

Nonbinding

This study

DLG7

chr14:54,727,987-54,727,999

GGTCGtccAGACC

Nonbinding

This study

ESR2

chr14:63,876,354-63,876,366

GACCAgccTGACC

Nonbinding

This study

THBS1

chr15:37,657,943-37,657,955

GGTCAatcCCACC

Nonbinding

This study

FLJ13710

chr15:69,737,514-69,737,526

AGTCAttgTTACC

Nonbinding

This study

FLJ13710

chr15:69,738,257-69,738,269

GGTCAatgTGCGC

Nonbinding

This study

FLJ13710

chr15:69,738,459-69,738,471

GCTCActtTGTCC

Nonbinding

This study

SH3GL3

chr15:82,077,053-82,077,065

GATCTtgcTGACC

Nonbinding

This study

SMAP-1

chr15:89,278,745-89,278,757

AGTCAatcTGTCC

Nonbinding

This study

ABCA3

chr16:2,321,166-2,321,178

GGTCTtttTTACC

Nonbinding

This study

HCFC1R1

chr16:3,015,149-3,015,161

GACCAgccTGACC

Nonbinding

This study

ADCY9

chr16:4,107,737-4,107,749

GGTCAggcTGGTC

Nonbinding

This study

ADCY9

chr16:4,108,935-4,108,947

GGTGAaaaTGTCC

Nonbinding

This study

CAPNS2

chr16:54,100,244-54,100,256

GGTCCgtcCGACC

Nonbinding

This study

PAFAH1B1

chr17:2,441,502-2,441,514

CGCCAtgtTGACC

Nonbinding

This study

IGFBP4

chr17:35,851,519-35,851,531

GATCActgTAACC

Nonbinding

This study

IGFBP4

chr17:35,853,510-35,853,522

GGTCAtgcTGCCC

Nonbinding

This study

RBBP8

chr18:18,766,140-18,766,152

GGTCAttcTGCTC

Nonbinding

This study

MKNK2

chr19:2,382,491-2,382,503

GGGCAgagTGAGC

Nonbinding

This study

BBC3

chr19:52,426,840-52,426,852

TGTCAttgTGTCC

Nonbinding

This study

BBC3

chr19:52,427,249-52,427,261

GGTCAggcTGGTC

Nonbinding

This study

GPBP6

chrY:169,893-169,905

GCTCAcgaTGACG

Nonbinding

This study

  1. Shown in bold and underlined are nucleotides that deviate from the consensus core ERE. ER, estrogen receptor; ERE, estrogen response element.